W1 (Pyridostigmine bromide extended-release 180 mg)
Pill imprint W1 has been identified as Pyridostigmine bromide extended-release 180 mg.
Pyridostigmine is used in the treatment of myasthenia gravis; dysautonomia; reversal of nondepolarizing muscle relaxants; nerve agent pretreatment and belongs to the drug class cholinergic muscle stimulants. Risk cannot be ruled out during pregnancy. Pyridostigmine 180 mg is not a controlled substance under the Controlled Substance Act (CSA).
- Imprint:
- W1
- Strength:
- 180 mg
- Color:
- Yellow
- Shape:
- Capsule-shape
- Availability:
- Prescription only
- Drug Class:
- Cholinergic muscle stimulants
- Pregnancy Category:
- C - Risk cannot be ruled out
- CSA Schedule:
- Not a controlled drug
- Manufacturer:
- Global Pharmaceuticals, Division of Impax Laboratories Inc.
More about pyridostigmine
Consumer resources
- Other brands: Mestinon, Regonol, Mestinon Timespan
Professional resources
Related treatment guides
Disclaimer:
Every effort has been made to ensure that the information provided is accurate, up-to-date, and complete, but no guarantee is made to that effect. If you have questions about the drugs you are taking, check with your doctor, nurse or pharmacist.
Copyright 2016 Drugs.com, National Library of Medicine, Truven Health Analytics and Cerner Multum, Inc. All Rights Reserved.
